PerkinElmer unveils LC 300 platform, SimplicityChrom software

By The Science Advisory Board staff writers

November 17, 2020 -- PerkinElmer has debuted its LC 300 platform and SimplicityChrom software, a package designed to combine high-performance liquid chromatography and ultrahigh-performance liquid chromatography with instrument control and data analysis.

Suitable for labs in multiple industries including pharmaceuticals, LC 300 provides ultraprecise gradient flows and low levels of dispersion, according to the vendor. Its autosampler features a built-in column oven and a color liquid-crystal display (LCD) screen that displays key status results without forcing users to log in to chromatography data system (CDS) software, PerkinElmer said. LC300 is available with multiple detector options and third-party driver support for commercially available CDS software.

The accompanying SimplicityChrom software enables customized workflows and supports 21 Code of Federal Regulations (CFR) Part 11 compliance, according to the firm. What's more, the software provides proactive alerts on consumable usage and required maintenance.

PerkinElmer debuts ChemOffice+ Cloud
PerkinElmer has introduced ChemOffice+ Cloud, a new application for its ChemDraw chemistry drawing software portfolio.
PerkinElmer to acquire Horizon Discovery for $383M
PerkinElmer has reached an agreement to acquire Horizon Discovery Group with an all-cash offer of approximately $383 million. The transaction is...
PerkinElmer introduces no-wash immunoassay for mitophagy dysfunction
PerkinElmer has debuted a no-wash ubiquitin phosphorylation at serine 65 immunoassay for studying defective mitophagy dysfunction associated with Parkinson's...
PerkinElmer immunoassay identifies anti-SARS-CoV-2 compounds
PerkinElmer's AlphaLisa immunoassay was used to support global research for effective COVID-19 therapeutics conducted by the National Center for Advancing...
PerkinElmer launches workstations for COVID-19 detection
PerkinElmer has launched a series of new workstations for SARS-CoV-2 testing.

Copyright © 2020

Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter